SpaceX is targeting a valuation of at least $1.8 trillion in its IPO.
SpaceX Is Said to Target $75 Billion in IPO at $135 Per Share
SpaceX is targeting a staggering $1.8 trillion valuation in its upcoming IPO at $135 per share, cementing Elon Musk as the 'god king' with absolute governance power.
Jun 3, 2026
23:38
Difficulty: Intermediate
Played
Bloomberg Intelligence
SpaceX Is Said to Target $75 Billion in IPO at $135 Per Share
SpaceX is targeting a staggering $1.8 trillion valuation in its upcoming IPO at $135 per share, cementing Elon Musk as the 'god king' with absolute governance power.
Jun 3, 2026
23:38
Difficulty: Intermediate
Played
Chapter
No indexed bits in this chapter.
Snapshots ()
Stats
Episode stats
Insight Overview
insights
chapters
Insight distribution
Sub-Categories
Speaker breakdown
Talk Time
Key Quotes ()
This episode
Cast
-
The space exploration company planning a monumental IPO targeting a $1.8 trillion valuation.
-
A leading medical technology company that reported strong quarterly earnings, sending its stock up 5%.
-
A major US department store chain that reported better-than-expected earnings and 3% comparable store growth.
-
The upscale department store banner owned by Macy's that experienced 10% sales growth.
-
A primary competitor to Medtronic in the cardiovascular and cardiac ablation space.
-
The department store chain acquired by Saks that has seen sales trends turn sharply negative.
-
The parent company of Saks Fifth Avenue, which filed for bankruptcy and struggled with inventory and vendor issues.
-
A major publicly traded peer in the aerospace launch industry compared alongside SpaceX.
-
Discussed as the biggest beneficiary of SpaceX's launch services, offering the largest low Earth orbit satellite constellation.
This episode
Claims & Sources
7 / 7 cited (100%)
Factual claims made this episode, and whether a source was named.
At a $135 share price, Elon Musk's net worth would be approximately $988 billion.
SpaceX plans to sell 555.6 million shares and target a $75 billion capital raise in its IPO.
Medtronic reported positive 124% growth in a key technology segment during its earnings report.
Macy's reported 3% comparable store sales growth for the quarter.
Bloomingdale's sales grew by 10% in the latest quarter.
Macy's average price increased by 8.3% during the quarter.
TL;DR
This episode analyzes SpaceX's monumental IPO plans, where the space pioneer is targeting a historic $1.8 trillion valuation at $135 per share [1] — George Ferguson "While satellite communication via Starlink is a major operational focus, the massive long-term upside of SpaceX lies in launching and opera…" 03:34 . Analysts discuss the strategic play of orbital AI data centers [1] — George Ferguson "While satellite communication via Starlink is a major operational focus, the massive long-term upside of SpaceX lies in launching and opera…" 03:34 and the stark corporate governance risks that leave Elon Musk as an untouchable 'god king' with absolute corporate control [3] — Matt Henriksen "124% Technology Growth Segment: The explosive growth in this core technology segment alleviated investor worries and drove a 5% daily bump …" 18:11 . Later, the focus shifts to Medtronic's earnings boost in heart devices[6] and Macy's success in capturing premium luxury retail market share via Bloomingdale's[8]. The key takeaway is that luxury retail resilience and advanced medical device innovation are outperforming broader market execution struggles.
#SpaceX IPO
#Corporate Governance
#Medical Technology
#Retail Earnings
#Department Stores
#SpaceX
#IPO
#Starlink
#Medtronic
#Macy's
#Bloomingdale's
#Retail
#Earnings
#Governance
#Elections
2 minute taster
Why Elon Musk is the 'God King' of SpaceX
The governance structure of SpaceX features extreme concentration of voting power. Elon Musk has been surrounded with such extensive rights and special privileges that he has absolute control and can never be terminated or overridden by shareholders.
The Real Value of SpaceX's IPO: AI Data Centers in Space
While satellite communication via Starlink is a major operational focus, the massive long-term upside of SpaceX lies in launching and operating AI data centers in space. This represents the ultimate bet for investors purchasing shares in the upcoming IPO.
Bloomingdale's Steals Market Share from Saks and Neiman
While Neiman Marcus saw double-digit sales declines and Saks Global struggled with vendor payments post-acquisition, Bloomingdale's capitalized on customer frustration and captured luxury market share through superior retail execution.
Look closer
Bloomberg Intelligence hosted by Paul Sweeney and Scarlet Fu features deep dives into SpaceX's potential IPO, Medtronic's positive earnings trend, and Macy's retail execution.
- Sum of the parts
- A valuation method that evaluates a company by valuing each of its business segments separately and adding them together.
- Dual-class shares
- A system of corporate governance where a company issues multiple classes of shares, with one class carrying superior voting rights.
- CMS
- The regulatory body responsible for administering the Medicare and Medicaid programs.
- GLPs
- Glucagon-like peptide-1; a class of medications used to treat type 2 diabetes and obesity.
- Cardiac ablation
- A medical procedure that uses heat or cold energy to scar small areas in the heart to correct abnormal heart rhythms.
- ANR function
- A metrics page on the Bloomberg Terminal representing the consensus analyst recommendations.
